Lakhsmi et al. revealed that HSP treatment in Swiss albino mice prevents cancer formation by alleviating LPO, modulating antioxidants enzymes like decreased NF-kB, PCNA, and CYP1A1. Here, CYP1A1 is linked to hereditary spastic paraplegia.